John Landers

A new study shows a small change in the KIFAP3 gene lengthens ALS survival time

posted on May 21, 2009 - 9:00pm
A variant version of the gene for a protein known as KIFAP3 has been found to increase survival time in people with sporadic (nonfamilial) ALS (amyotrophic lateral sclerosis, or Lou Gehrig's disease) by an average of 14 months.

New content is being added every day. Please check back again.